Various Types of Stem Cells, Including a Population of Very Small Embryonic-Like Stem Cells, Are Mobilized into Peripheral Blood in Patients with Crohn’s Disease

This study from Oxford Academic examines how mesenchymal stem cells (MSCs) could be used to treat inflammatory bowel disease (IBD), a chronic condition that causes inflammation in the digestive tract. Researchers discuss the unique ability of MSCs to reduce inflammation and promote tissue repair, which makes them a promising option for treating IBD. The study reviews current research on how MSCs are delivered to patients, their safety, and their effectiveness in reducing symptoms and healing damaged tissue. It highlights the potential of MSC-based therapies as a new approach for patients who don’t respond well to traditional treatments.